What are the risks from 'aerosol-generating procedures’ in the treatment of patients with COVID-19?

Thorax Podcast

English - November 26, 2021 11:48 - 10 minutes - ★★★★ - 1 rating
Science Health & Fitness Medicine medicine health interviews bmj debates conference roundtable british medical journal Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: What are the risks from ’aerosol-generating procedures’ in the treatment of patients with COVID-19?

Next Episode: Better asthma control, half of the carbon footprint with climate-friendly inhalers

Do hospitalised COVID-19 patients receiving treatment with CPAP and HFNOT present a significant added risk of viral contamination to the surrounding environment used by healthcare workers?
And is there enough evidence to suggest or recommend levels of PPE that should be used for healthcare workers caring for patients on CPAP or HFNOT?
Two of the main questions this short podcast addresses. Rachael Moses, Multimedia Editor Thorax BMJ, interviews Dr Chris Green, Consultant in Infectious Diseases & General (Internal) Medicine, University Hospitals Birmingham NHS Foundation Trust.
Read the two related papers:
SARS-CoV-2 environmental contamination from hospitalised patients with COVID-19 receiving aerosol-generating procedures - https://thorax.bmj.com/content/early/2021/11/01/thoraxjnl-2021-218035

Coughs and sneezes spread diseases: but do ‘aerosol generating’ procedures? - https://thorax.bmj.com/content/early/2021/11/10/thoraxjnl-2021-218133